首页> 外文期刊>Arteriosclerosis, thrombosis, and vascular biology >Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Sympathetic Nerve Distribution and Pulmonary Artery Remodeling
【24h】

Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Sympathetic Nerve Distribution and Pulmonary Artery Remodeling

机译:肺动脉高压交感神经分布和肺动脉重塑的Transthoracic肺动脉患者

获取原文
获取原文并翻译 | 示例
       

摘要

Objective- Pulmonary arterial hypertension is characterized by progressive pulmonary vascular remodeling and persistently elevated mean pulmonary artery pressures and pulmonary vascular resistance. We aimed to investigate whether transthoracic pulmonary artery denervation (TPADN) attenuated pulmonary artery (PA) remodeling, improved right ventricular (RV) function, and affected underlying mechanisms. We also explored the distributions of sympathetic nerves (SNs) around human PAs for clinical translation. Approach and Results- We identified numerous SNs in adipose and connective tissues around the main PA trunks and bifurcations in male Sprague Dawley rats, which were verified in samples from human heart transplant patients. Pulmonary arterial hypertensive rats were randomized into TPADN and sham groups. In the TPADN group, SNs around the PA trunk and bifurcation were completely and accurately removed under direct visualization. The sham group underwent thoracotomy. Hemodynamics, RV function, and pathological changes in PA and RV tissues were measured via right heart catheterization, cardiac magnetic resonance imaging, and pathological staining, respectively. Compared with the sham group, the TPADN group had lower mean pulmonary arterial pressures, less PA and RV remodeling, and improved RV function. Furthermore, TPADN inhibited neurohormonal overactivation of the sympathetic nervous system and renin-angiotensin-aldosterone system and regulated abnormal expressions and signaling of neurohormone receptors in local tissues. Conclusions- There are numerous SNs around the rat and human main PA trunks and bifurcations. TPADN completely and accurately removed the main SNs around PAs and attenuated pulmonary arterial hypertensive progression by inhibiting excessive activation of the sympathetic nervous system and renin-angiotensin-aldosterone system neurohormone-receptor axes.
机译:目的 - 肺动脉高压的特征在于进行肺血管重塑和持续升高的平均肺动脉压力和肺血管抗性。我们的目的是探讨经脉冲肺动脉消除(TPADN)衰减肺动脉(PA)重塑,改善右心室(RV)功能,以及受影响的潜在机制。我们还探讨了临床翻译的人类PAS周围的交感神经(SNS)的分布。方法和结果 - 我们在主要PA中的脂肪和结缔组织中鉴定了许多SNS,以及雄性Sprague Dawley大鼠的分叉分叉,其在来自人类心脏移植患者的样本中验证。肺动脉高血压大鼠随机分为TPADN和假组。在TPADN组中,在直接可视化下,完全准确地除去PA躯干和分叉周围的SNS。假手术组接受了胸廓切开术。 PA和RV组织的血流动力学,RV功能和病理变化分别通过右心导管,心脏磁共振成像和病理染色来测量。与假群相比,TPADN组的平均肺动脉压低,较少的PA和RV重塑,以及改善的RV功能。此外,TPADN抑制了交感神经系统和肾素 - 血管紧张素 - 醛固酮系统的神经异常过度激活,并调节了局部组织中神经期受体的异常表达和信号传导。结论 - 大鼠周围有许多SNS和人类的主要PA树干和分叉。 TPADN通过抑制交感神经系统和肾素 - 血管紧张素 - 醛固酮系统神经期受体轴的过度激活,完全和准确地除去PAS周围的主SN和减弱肺动脉高血压进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号